Water-soluble 2,3,7,8-tetrachlorodibenzo-p-dioxin complex with human α-fetoprotein: Properties, toxicity in vivo and antitumor activity in vitro

FEBS Letters

Volumn 450, Issue 1-2, 1999, Pages 49-51

  Sotnichenko, Alexander I ^a   Severin, Sergey E ^a   Posypanova, Galina A ^a   Feldman, Natalya B ^a   Grigor'Ev, Michael I ^b   Severin, Eugene S ^b   Petrov, Rem V ^b  

^a Moscow Research Institute of Medical Ecology   (Russian Federation)

^b Simferopolsky Blvd 8 113149   (Russian Federation)

Author keywords

Fetoprotein; 2,3,7,8 Tetrachlorodibenzo p dioxin; Complex; Embryotoxicity; Solubility; Toxicity

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ALPHA FETOPROTEIN; OIL; WATER;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL STRAIN MCF 7; COMPLEX FORMATION; CONTROLLED STUDY; DRUG BINDING; DRUG SOLUBILITY; DRUG TRANSPORT; EMBRYOTOXICITY; FEMALE; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; LD 50; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TERATOGENICITY;

ALPHA-FETOPROTEINS; ANIMALS; ANTINEOPLASTIC AGENTS; HUMANS; INJECTIONS, INTRAVENOUS; MICE; SOLUBILITY; TETRACHLORODIBENZODIOXIN; TUMOR CELLS, CULTURED;

EID: 0033042644     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(99)00440-8     Document Type: Article

References (24)

1. Skene S.A., Dewhurst I.C., Greenberg M. Human Toxicol. 8:1989;173-203.
2. Fingerhut M.A., Halpern W.E., Marlow D.A., Piacitelle L.A., Honcher P.A., Sweeney M.H., Griefe A.L., Dill P.A., Steenland K., Suruda A.J. New Engl. J. Med. 352:1991;212-218.
3. Kogevinas M., Saracei R., Winkleman R. Cancer Causes Control. 4:1993;457-462.
4. Manz A., Barger J., Dwyer J.H. Lancet. 338:1991;959-965.
5. Zaber A., Messerer P., Huber P. Int. Arch. Occup. Environ. Health. 62:1990;139-157.
6. Holsapple M.P., Morris D.L., Wood S.C., Snyder N.K. Annu. Rev. Pharmacol. Toxicol. 31:1991;73-100.
7. Poland A., Knutson J.C. Annu. Rev. Pharmacol. Toxicol. 22:1982;517-554.
8. Thomas, K.B. and Colburn, T. (1992) In: Chemically Induced Alterations in Sexual and Functional Development: The Wildlife/Human Connection (Colburn, T. and Clement, C., Eds.), pp. 365-394, Princeton University Press, Princeton, NJ.
9. Kuntsevich A.D., Troshkin N.M., Baulin S.I., Golovkov V.F., Nedoshivin Yu.K., Rembovski V.R. Dokl. Acad. Nauk. RF. 340:1995;268-270.
10. McConnell E.E., Moore J.A., Haseman J.K., Harris M.W. Toxicol. Appl. Pharmacol. 44:1978;335-356.
11. Tsyrlov, I.B. (1990) In: Chlorinated Dioxins: Biological and Medicinal Aspects, pp. 10-33, Analytical Review, Novosibirsk.
12. Courtney K.D., Moore J.A. Toxicol. Appl. Pharmacol. 20:1971;396-403.
13. McNulty W.P. Am. J. Pharmacol. 6:1984;41-47.
14. Brunstrom B., Kihlstrom I., Lundkvist U. Acta Pharmacol. Toxicology. 50:1982;100-103.
15. Severin S.E., Moskaleva E.Yu., Posynapova G.A., Koromyslova I.A., Shmyrev I.I., Krivonos A.V., Myagkikh I.V., Feldman N.B., Finakova G.V., Katukov V.Yu., Luzhkov Yu.M., Nakachian R., Andreani J., Severin E.S. Tumor Targeting. 2:1996;299-306.
16. Mosmann T. J. Immunol. Methods. 65:1983;55-63.
17. Vos J.G., Moore J.A., Zinkl J.G. Toxicol. Appl. Pharmacol. 29:1974;229-241.
18. Rordorf B.F. Chemosphere. 18:(1-6):1989;783-788.
19. Nunez, E.A., Benassayag, C., Christeff, N., Essien, M., Hassid, J., Martin, M.E., Savu, L., Vallette, G. and Vranckx, R. (1987) in: Biological Activities of Alpha-Fetoprotein (Mizejewski, G.J. and Jacobson, H.I., Eds.), Vol. 1, pp. 3-18, CRC Press, Boca Raton, FL.
20. Herve, F., Rajkowski, K., Martin, M.-T. and Cittanova, N. (1987) in: Biological Activities of Alpha-Fetoprotein (Mizejewski, G.J. and Jacobson, H.I., Eds.), Vol. 1, pp. 51-67, CRC Press, Boca Raton, FL.
21. Dickerson R., Keller L.H., Safe S. Toxicol. Appl. Pharmacol. 164:1995;287-298.
22. Astroff B., Safe S. Biochem. Pharmacol. 39:1990;485-488.
23. Gierthy J.F., Lincoln D.W., Gillespie M.B., Seeger J.I., Martinez H.L., Dickerman H.W., Kumar S.A. Cancer Res. 47:1987;6198-6203.
24. Gierthy J.F., Bennett J.A., Bradley L.M., Cutler D.S. Cancer Res. 53:1993;3149-3153.